Melina Sophie Kurte

5PUBLICATIONS
15CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Major global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 01, 2026
Comparative Cost and Utilization Analysis of CAR-T Therapy and Autologous Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma in Germany: Insights from Statutory Health Insurance Billing and Nationwide Inpatient Data.

|Dec 26, 2025
Evaluating the health economic impact of cefepime/enmetazobactam in complicated urinary tract infections in the German setting: a cost analysis from payer perspective.

Johanna Röder, Sebastian M Wingen-Heimann, Danila Seidel

|Jun 10, 2024
Time-dependent cost comparison and health economic impact analysis of second-line interventions for transplant-ineligible patients with relapsed or refractory diffuse large B cell lymphoma.

Melina Sophie Kurte, Ann-Cathrine Siefen, Florian Jakobs

|May 07, 2024
A retrospective budget impact analysis of fidaxomicin treatment for Clostridioides difficile infections (CDI) in Germany.

Ann-Cathrine Siefen, Melina Sophie Kurte, Anna Marie Bauer

|Mar 08, 2024
Cost-benefit evaluation of advanced therapy lines in metastatic triple-negative breast cancer in Germany.

Amelie Wickmann, Melina Sophie Kurte, Julia Jeck

Pageof 1

Frequent Collaborators

5 joint publications

Florian Kron

4 joint publications

Ann-Cathrine Siefen

2 joint publications

Sebastian Wingen-Heimann

2 joint publications

Oliver A Cornely